![](/img/cover-not-exists.png)
Phase II study of esorubicin (4 ′ deoxydoxorubicin) in anthracycline naive patients with ovarian cancer
Michael D. Green, James L. Speyer, James C. Wernz, Nicoletta Colombo, Uziel Beller, Franco M. Muggia, E. Mark BeckmanVolume:
8
Language:
english
Pages:
4
DOI:
10.1007/bf00171850
Date:
August, 1990
File:
PDF, 323 KB
english, 1990